CERT Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 107434 min ago

@ $17.66

Ausgestellt: 14 Feb 2024 @ 19:37

Rendite: -6.17%

Vorheriges Signal: Feb 14 - 18:03

Vorheriges Signal: Kaufen

Rendite: 1.15 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 22:00):

Stats
Tagesvolumen	300 239
Durchschnittsvolumen	529 444
Marktkapitalisierung	2.65B
EPS	$0 ( 2024-02-29 )
Nächstes Ertragsdatum	( $0.100 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-47.34
ATR14	$0.0120 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Feehery William F	Buy	124 779	Restricted Stock Units
2024-04-02	Smith Patrick F	Sell	5 264	Common Stock
2024-04-02	Smith Patrick F	Sell	649	Common Stock
2024-04-02	Smith Patrick F	Sell	3 024	Common Stock
2024-04-02	Smith Patrick F	Sell	328	Common Stock

INSIDER POWER
30.50
Last 100 transactions
Buy: 798 344 \| Sell: 442 671

Volumen Korrelation

Lang: -0.38 (neutral)

Kurz: 0.63 (weak)

Signal:(54.846) Neutral

Certara, Inc. Korrelation

10 Am meisten positiv korreliert
RELY	0.963
MSAC	0.958
KAII	0.953
ALTR	0.951
APXI	0.95
LMB	0.946
AEAC	0.945
ANSS	0.944
MLAI	0.944
DSEY	0.943

10 Am meisten negativ korreliert
GOOD	-0.959
CSSEP	-0.958
HALO	-0.955
CBNK	-0.952
SFST	-0.947
WASH	-0.947
WTBA	-0.946
MCBS	-0.946
UTHR	-0.946
BMRA	-0.945

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Certara, Inc. Korrelation - Währung/Rohstoff

-0.61
( weak negative )

-0.40
( neutral )

0.00
( neutral )

-0.22
( neutral )

-0.02
( neutral )

0.64
( weak )

Certara, Inc. Finanzdaten

Annual	2023
Umsatz:	$354.34M
Bruttogewinn:	$167.79M (47.35 %)
EPS:	$-0.350

FY	2023
Umsatz:	$354.34M
Bruttogewinn:	$167.79M (47.35 %)
EPS:	$-0.350

FY	2022
Umsatz:	$335.64M
Bruttogewinn:	$203.07M (60.50 %)
EPS:	$0.0939

FY	2021
Umsatz:	$286.10M
Bruttogewinn:	$174.49M (60.99 %)
EPS:	$-0.0900

Financial Reports:

No articles found.

Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.